{"id":"https://openalex.org/W4361879809","doi":"https://doi.org/10.1158/1078-0432.22439305.v1","title":"Supplementary Tables S1-S3 from Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel","display_name":"Supplementary Tables S1-S3 from Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361879809","doi":"https://doi.org/10.1158/1078-0432.22439305.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22439305.v1","doi":"https://doi.org/10.1158/1078-0432.22439305.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22439305.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22439305.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062284417","display_name":"Gerald J. Fetterly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerald J. Fetterly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000740229","display_name":"Thaddeus H. Grasela","orcid":"https://orcid.org/0000-0002-2103-8206","observed_orcids":["https://orcid.org/0000-0002-2103-8206"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thaddeus H. Grasela","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065420625","display_name":"Jeffrey W. Sherman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey W. Sherman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012368118","display_name":"Jeanne L. Dul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeanne L. Dul","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035404908","display_name":"Amy Y. Grahn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy Grahn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Diane Lecomte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diane Lecomte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067609128","display_name":"Jill Fiedler\u2010Kelly","orcid":"https://orcid.org/0009-0003-8128-8789","observed_orcids":["https://orcid.org/0009-0003-8128-8789"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jill Fiedler-Kelly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013636222","display_name":"Nevena Damjanov","orcid":"https://orcid.org/0000-0002-4195-7277","observed_orcids":["https://orcid.org/0000-0002-4195-7277"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nevena Damjanov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005003137","display_name":"Mayer Fishman","orcid":"https://orcid.org/0000-0003-0185-1432","observed_orcids":["https://orcid.org/0000-0003-0185-1432"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mayer Fishman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Michael P. Kane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael P. Kane","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074861706","display_name":"Eric H. Rubin","orcid":"https://orcid.org/0000-0002-8032-7913","observed_orcids":["https://orcid.org/0000-0002-8032-7913"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric H. Rubin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5022891785","display_name":"Antoinette R. Tan","orcid":"https://orcid.org/0000-0002-7895-7000","observed_orcids":["https://orcid.org/0000-0002-7895-7000"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antoinette R. Tan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.42480000853538513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.42480000853538513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.2809999883174896,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.17419999837875366,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liposomal-paclitaxel","display_name":"liposomal paclitaxel","score":0.8980000019073486},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9520000219345093},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.8949999809265137},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.4729999899864197},{"id":"https://openalex.org/keywords/liposomal-drug-delivery","display_name":"liposomal drug delivery","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8270108699798584},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7836486101150513},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.737484335899353},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6830025315284729},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.653222382068634},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6048644185066223},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4189611077308655},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.27511337399482727},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1908838152885437},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.15081602334976196},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22439305.v1","doi":"https://doi.org/10.1158/1078-0432.22439305.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22439305.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22439305","doi":"https://doi.org/10.1158/1078-0432.22439305","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22439305","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S3_from_Pharmacokinetic_Pharmacodynamic_Modeling_and_Simulation_of_Neutropenia_during_Phase_I_Development_of_Liposome-Entrapped_Paclitaxel/22439305/1/files/39890137.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22439305","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S3_from_Pharmacokinetic_Pharmacodynamic_Modeling_and_Simulation_of_Neutropenia_during_Phase_I_Development_of_Liposome-Entrapped_Paclitaxel/22439305","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22439305.v1","doi":"https://doi.org/10.1158/1078-0432.22439305.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22439305.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361879809.pdf","grobid_xml":"https://content.openalex.org/works/W4361879809.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2155519793","https://openalex.org/W4361943030","https://openalex.org/W2335962969","https://openalex.org/W1998030472","https://openalex.org/W2019763196","https://openalex.org/W2084657557","https://openalex.org/W7075312069","https://openalex.org/W3026042744","https://openalex.org/W3128163539","https://openalex.org/W7146545820"],"abstract_inverted_index":{"Supplementary":[0],"Tables":[1],"S1-S3":[2],"from":[3],"Pharmacokinetic/Pharmacodynamic":[4],"Modeling":[5],"and":[6],"Simulation":[7],"of":[8,14],"Neutropenia":[9],"during":[10],"Phase":[11],"I":[12],"Development":[13],"Liposome-Entrapped":[15],"Paclitaxel":[16]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-05T00:00:00"}